Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies
This study is currently recruiting participants.
Verified December 2012 by National Cancer Institute (NCI)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01364051
First received: May 26, 2011
Last updated: December 21, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | January 2100 (Final data collection date for primary outcome measure) |